Nocion Therapeutics

Funding and NIH signals

• SEC Form D raise Raised $23M (Form D filed Mar 13, 2026). SEC Form D 0001841279-26-000003 (Mar 13, 2026)
  Evidence (1 event)

  • Mar 13, 2026 · SEC Form D 0001841279-26-000003
    Name of Issuer: Nocion Therapeutics, Inc.; CIK: 1841279; Address: Watertown, MA; Submission type: D; Filing date: 2026-03-13; Industry Group: Pharmaceuticals; Date of First Sale: 2025-12-15; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 22999999; Total Amount Sold: 22999999; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Raises and deals from press releases

• Raise Series B · $62M · announced Mar 4, 2024 Company release ↗
  Source quote

  • Mar 4, 2024 · Company release ↗
    “Nocion Therapeutics Announces $62 Million Series B Financing to Advance Lead Program in Cough into Later Stage Development Financing led by new investors Arkin Bio Capital and Monograph Capital Participation from additional new and existing investors and a strategic Financing will support a global”

Raises announced in these releases: $62M disclosed.

From the company’s own releases; this list is partial. All raises and deals